First Approval of Regenerative Medical Products under the PMD Act in Japan
Authors:
- 1 April 2016
- journal article
- Published by Elsevier in Cell Stem Cell
- Vol. 18 (4) , 434-435
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III studyInternational Journal of Hematology, 2015
- New Japanese Initiatives on Stem Cell TherapiesCell Stem Cell, 2015
- Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart DiseaseCirculation Journal, 2015
- Korean deaths spark inquiryNature, 2010